Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy.

Published in:

Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 212, doi. 10.1111/apt.14410

By:

• Bar‐Yoseph, H.;
• Levhar, N.;
• Selinger, L.;
• Manor, U.;
• Yavzori, M.;
• Picard, O.;
• Fudim, E.;
• Kopylov, U.;
• Eliakim, R.;
• Ben‐Horin, S.;
• Chowers, Y.;
• Ungar, B.

Publication type:

Article